❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Tumor Biology ❭
Page visits: 29
Scroll to top

Home Institute for Cancer Research Dept. of Tumor Biology

  • Resources and expertise
  • Kjersti Flatmark's group
  • Eivind Hovig's group
  • Jørgen Wesche's group
  • G. Mælandsmo's group
  • Project groups Tumor Biology
  • Publications
  • Staff
  • Vacant positions
  • News

Recent publications

Kotsopoulos J, Seca M, Gronwald J, Huzarski T, Møller P, Kim RH, Singer CF, Karlan B, Aeilts A, Ramón Y Cajal T, Pal T, Eisen A, Bordeleau L, Foulkes WD, Tung N, Couch F, Neuhausen SL, Zakalik D, Cybulski C, Olopade O, Metcalfe K, Fruscio R, Sun P, Lubinski J, Narod SA (2025)
Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2
J Natl Cancer Inst (in press)
DOI 10.1093/jnci/djaf363, PubMed 41403285

Riaza Montes M, Suárez B, Solano-Iturri JD, Lecumberri D, Iturregui AM, Lawrie CH, Armesto M, Nunes-Xavier CE, Pulido R, López JI, Angulo JC, Larrinaga G (2025)
Fibroblast Activation Protein Alpha (FAP) Expression Is Associated with Disease Recurrence and Poor Response to Tyrosine Kinase Inhibitors in Advanced Clear Cell Renal Cell Carcinoma
Int J Mol Sci, 26 (22)
DOI 10.3390/ijms262211112, PubMed 41303595

Lapão A, Johnson LS, Trachsel-Moncho L, Rodgers SJ, Singh S, Ng MYW, Nakken S, Eskelinen EL, Simonsen A (2025)
The RAB27A effector SYTL5 regulates mitophagy and mitochondrial metabolism
Elife, 14
DOI 10.7554/eLife.105541, PubMed 41294009

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)